Literature DB >> 6437984

Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line.

M W Vermeulen, G R Gray.   

Abstract

It has previously been established that muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine) is an effective immunostimulant whose primary target cell type is the macrophage. Muramyl dipeptide is known to be structurally identical to a portion of the monomer unit of peptidoglycan, a nearly ubiquitous component of bacterial cell walls. To establish whether muramyl dipeptide or glycopeptides structurally related to it are formed as a result of macrophage processing of peptidoglycan, Bacillus subtilis cell walls radiolabeled in the muramic acid, glucosamine, and alanine residues of the constituent peptidoglycan were incubated in the presence of the cultured macrophage-like cell line RAW264, and the glycopeptides which released into the medium were fractionated and analyzed. Although muramyl dipeptide was not found in the culture medium, at least three glycopeptides structurally related to it were found, namely GlcNAc-MurNAc-Ala-isoGln-Dap-Ala, GlcNAc-MurNAc-Ala-isoGln-Dap, and GlcNAc-MurNAc-Ala-isoGln.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6437984      PMCID: PMC261558          DOI: 10.1128/iai.46.2.476-483.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.

Authors:  P Ralph; I Nakoinz
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

Review 3.  Biochemical criteria for activated macrophages.

Authors:  M L Karnovsky; J K Lazdins
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

4.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

5.  Adjuvant activity of monomeric bacterial cell wall peptidoglycans.

Authors:  A Adam; R Ciorbaru; F Ellouz; J F Petit; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-02-04       Impact factor: 3.575

6.  Persistence of antigen on the surface of macrophages.

Authors:  E R Unanue; J C Cerottini; M Bedford
Journal:  Nature       Date:  1969-06-21       Impact factor: 49.962

7.  Biosynthesis of teichoic acids.

Authors:  R Bracha; M Chang; F Fiedler; L Glaser
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

8.  Interaction of bacterial cell wall polymers and rat macrophages.

Authors:  J H Schwab; R Smialowicz
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

9.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  Degradation of streptococcal cell wall antigens in vivo.

Authors:  J H Schwab; S H Ohanian
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

View more
  17 in total

1.  Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide.

Authors:  T A Flak; L N Heiss; J T Engle; W E Goldman
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Somnogenic activities of synthetic lipid A.

Authors:  A B Cady; S Kotani; T Shiba; S Kusumoto; J M Krueger
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 3.  Sleep and Microbes.

Authors:  J M Krueger; M R Opp
Journal:  Int Rev Neurobiol       Date:  2016-08-31       Impact factor: 3.230

Review 4.  Periodontal innate immune mechanisms relevant to atherosclerosis.

Authors:  S Amar; M Engelke
Journal:  Mol Oral Microbiol       Date:  2014-12-29       Impact factor: 3.563

5.  Bordetella pertussis tracheal cytotoxin and other muramyl peptides: distinct structure-activity relationships for respiratory epithelial cytopathology.

Authors:  K E Luker; J L Collier; E W Kolodziej; G R Marshall; W E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.

Authors:  M J Janusz; R E Esser; J H Schwab
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Degradation of muramyl dipeptide by mammalian serum.

Authors:  J Harrison; A Fox
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Bacillus anthracis spores and lethal toxin induce IL-1beta via functionally distinct signaling pathways.

Authors:  Tae Jin Kang; Subhendu Basu; Lei Zhang; Karen E Thomas; Stefanie N Vogel; Les Baillie; Alan S Cross
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

9.  Structural characteristics of peptidoglycan fragments required to prime mice for induction of anaphylactoid reactions by lipopolysaccharides.

Authors:  H Takada; Y Kawabata; S Kawata; S Kusumoto
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

10.  G(AnH)MTetra, a naturally occurring 1,6-anhydro muramyl dipeptide, induces granulocyte colony-stimulating factor expression in human monocytes: a molecular analysis.

Authors:  W H Dokter; A J Dijkstra; S B Koopmans; A B Mulder; B K Stulp; M R Halie; W Keck; E Vellenga
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.